PharmaLex is a leading provider of specialized services for the pharmaceutical, biotech and MedTech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide. Our Statistics and Data Science team provides analytical expertise in the design, analysis, and interpretation of complex data to pharmaceutical and biotechnology companies. We proactively identify and provide analytical solutions to the data complexities inherent to the healthcare industry. The variety, volume and complexity of data are ever increasing. PharmaLex assists clients in navigating the landscape of high-dimensional data, including real world data, data derived from OMIC and electronic technologies. To meet these challenges, BSSI uses a collaborative approach bringing together statisticians, bioinformaticians, data scientists, statistical geneticists, epidemiologists, and programmers. As a team we work alongside our clients to support drug target identification and prioritization projects, biomarker development efforts, and complex drug, biologic and medical device studies. Analytical Services • Biostatistics • Bioinformatics • Data science Biomarker Expertise • Drug Target ID • Real World Data and Evidence • Biobanks and Reference Populations • Preclinical and Clinical Biomarker